Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FYP79
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,987
Award facts
- Contract value 100% obligated
- $38,986.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,986.77 to DMS Pharmaceutical Group Inc. on August 18, 2025, for the supply of Keytruda 100 mg/4 mL vials. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with DLA's SPE2DB program, valued at $499,999,999 through November 2026. The contract utilizes firm fixed-price pricing and does not include a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility, with an ultimate completion date of September 9, 2025.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, providing comprehensive pharmaceutical distribution to Department of Defense healthcare facilities nationwide. The company's portfolio under the broader IDC encompasses a wide range of branded and generic prescription drugs, biologics, and medical consumables spanning oncology treatments, vaccines, auto-injectors, and specialty medications. This particular delivery order for Keytruda, an oncology therapeutic, exemplifies DMS Pharmaceutical Group's role in supporting military health systems' pharmaceutical needs and demonstrates the company's established capability in delivering high-value specialty pharmaceutical products to federal agencies.
Quick answers
Who was awarded contract SPE2DB25FYP79?
SPE2DB25FYP79 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FYP79 worth?
The government has obligated $38,987 on SPE2DB25FYP79.
Is contract SPE2DB25FYP79 an order under another contract?
Yes. SPE2DB25FYP79 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYP79 competed?
The extent of competition for SPE2DB25FYP79 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award